| SSBP2 |
P81877
|
single stranded DNA binding protein 2
|
|
1.00 |
0.659 |
0.269 |
| CD5 |
P06127
|
CD5 molecule
|
|
2.3E-10 |
0.682 |
0.308 |
| HLX |
Q14774
|
H2.0 like homeobox
|
|
0.88 |
0.716 |
0.308 |
| TLX1 |
P31314
|
T cell leukemia homeobox 1
|
|
0.74 |
0.644 |
0.308 |
| IGL |
|
immunoglobulin lambda locus
|
|
|
0.659 |
0.346 |
| GCSAM |
Q8N6F7
|
germinal center associated signaling and motility
|
|
6.4E-02 |
0.705 |
0.346 |
| ZBTB17 |
Q13105
|
zinc finger and BTB domain containing 17
|
|
0.98 |
0.674 |
0.385 |
| PIAS2 |
O75928
|
protein inhibitor of activated STAT 2
|
|
1.00 |
0.682 |
0.385 |
| PTPRO |
Q16827
|
protein tyrosine phosphatase receptor type O
|
|
1.2E-05 |
0.656 |
0.423 |
| CD37 |
P11049
|
CD37 molecule
|
|
4.4E-06 |
0.647 |
0.462 |
| MLLT10 |
P55197
|
MLLT10 histone lysine methyltransferase DOT1L cofactor
|
Transcription factor
|
1.00 |
0.551 |
0.462 |
| IGK |
|
immunoglobulin kappa locus
|
|
|
0.647 |
0.462 |
| UHMK1 |
Q8TAS1
|
U2AF homology motif kinase 1
|
Kinase
|
0.83 |
0.674 |
0.462 |
| TCL1A |
P56279
|
T cell leukemia/lymphoma 1A
|
|
5.7E-10 |
0.558 |
0.500 |
| TCL1B |
O95988
|
T cell leukemia/lymphoma 1B
|
|
1.0E-02 |
0.561 |
0.500 |
| MIR16-1 |
|
microRNA 16-1
|
|
|
0.623 |
0.500 |
| TRB |
P0DSE2
|
T cell receptor beta locus
|
|
|
0.636 |
0.538 |
| TRG |
|
T cell receptor gamma locus
|
|
|
0.631 |
0.538 |
| PICALM |
Q13492
|
phosphatidylinositol binding clathrin assembly protein
|
Transporter
|
1.00 |
0.592 |
0.538 |
| PIM2 |
Q9P1W9
|
Pim-2 proto-oncogene, serine/threonine kinase
|
Kinase
|
0.95 |
0.606 |
0.538 |
| H3P47 |
|
H3 histone pseudogene 47
|
|
|
0.603 |
0.538 |
| CD79B |
P40259
|
CD79b molecule
|
Receptor
|
0.92 |
0.576 |
0.577 |
| PRAME |
P78395
|
preferentially expressed antigen in melanoma
|
|
2.4E-07 |
0.531 |
0.577 |
| MSI2 |
Q96DH6
|
musashi RNA binding protein 2
|
|
0.99 |
0.592 |
0.577 |
| BTLA |
Q7Z6A9
|
B and T lymphocyte associated
|
|
2.1E-02 |
0.593 |
0.577 |